TY - JOUR
T1 - Cognitive impairment in bipolar disorder
T2 - Neurodevelopment or neurodegeneration? An ECNP expert meeting report
AU - Goodwin, Guy M.
AU - Martinez-Aran, A.
AU - Glahn, David C.
AU - Vieta, Eduard
N1 - Funding Information:
The support of the Spanish Ministry of Health, Instituto Carlos III, CIBER de Salud Mental. One of the authors (AMA) is funded by the Spanish Ministry of Health, Instituto Carlos III through a “Miguel Servet” postdoctoral contract.
PY - 2008/11
Y1 - 2008/11
N2 - This is a report arising from an ECNP expert meeting. Recent studies have focussed on cognitive problems in manic-depressive illness and a few have addressed premorbid neuropsychological functioning. The results are not fully consistent but seem to point to a neurodegenerative model, rather than a neurodevelopmental one, for some cognitive domains. There is agreement that cognitive dysfunction is highly correlated with psychosocial functioning. The neurobiological and clinical implications of recent findings will be discussed. Treatments to reduce subsyndromal symptoms and relapses may indirectly improve neurocognitive deficits and this should be better documented. Moreover, neurocognitive impairment in bipolar disorder should be considered a potential therapeutic target, so that research should focus on new drugs and psychological interventions, including neurocognitive rehabilitation, addressed to improve not only the cognition but also the functional outcome of this population.
AB - This is a report arising from an ECNP expert meeting. Recent studies have focussed on cognitive problems in manic-depressive illness and a few have addressed premorbid neuropsychological functioning. The results are not fully consistent but seem to point to a neurodegenerative model, rather than a neurodevelopmental one, for some cognitive domains. There is agreement that cognitive dysfunction is highly correlated with psychosocial functioning. The neurobiological and clinical implications of recent findings will be discussed. Treatments to reduce subsyndromal symptoms and relapses may indirectly improve neurocognitive deficits and this should be better documented. Moreover, neurocognitive impairment in bipolar disorder should be considered a potential therapeutic target, so that research should focus on new drugs and psychological interventions, including neurocognitive rehabilitation, addressed to improve not only the cognition but also the functional outcome of this population.
KW - Bipolar disorder
KW - Cognitive impairments
KW - Executive functions
KW - Neurodegeneration
UR - http://www.scopus.com/inward/record.url?scp=53149083344&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=53149083344&partnerID=8YFLogxK
U2 - 10.1016/j.euroneuro.2008.07.005
DO - 10.1016/j.euroneuro.2008.07.005
M3 - Review article
C2 - 18725178
AN - SCOPUS:53149083344
SN - 0924-977X
VL - 18
SP - 787
EP - 793
JO - European Neuropsychopharmacology
JF - European Neuropsychopharmacology
IS - 11
ER -